SciBase: Interim report

The first quarter in figures  The first quarter in figures  Important events during the quarter  Important events after the end of the period  This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET onMay 13, 2025. This interim report report has not been subject to review by the Company's...

The first quarter in figures 

Important events during the quarter 

Important events after the end of the period 

This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on May 13, 2025.

This interim report report has not been subject to review by the Company's auditors

Contact person:

Michael Colérus, CFO, +46 70 341 34 72

For additional information, please contact: Pia Renaudin, CEO, tel. +46732069802, e-mail: [email protected]

Certified Advisor (CA):

Carnegie Investment Bank AB (publ) Phone: +46 (0)73 856 42 65 E-mail: [email protected]

About SciBase 

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/interim-report,c4149173

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/scibase-interim-report-302453461.html